Search results
Results From The WOW.Com Content Network
The Sackler family is an American family who owned the pharmaceutical company Purdue Pharma and later founded Mundipharma. [1] Purdue Pharma, and some members of the family, have faced lawsuits regarding overprescription of addictive pharmaceutical drugs, including OxyContin.
Purdue Pharma L.P. Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants. [ 1][ 2] The company manufactured ...
Sackler joined Purdue Pharma in 1971, as assistant to his father, the company's president. [15] He became head of research and development and head of marketing. Sackler was a key figure in the development of Oxycontin, being the moving force behind Purdue Pharma's research around 1990 that pushed Oxycontin to replace MS Contin that was about to have generic competition.
On Dec. 4, 2023, the Supreme Court will hear arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from ...
Purdue Pharma. It's a rare bankruptcy case for the court. At issue is whether the Sacklers should be given what is known as "third-party release" in exchange for giving $6 billion to help victims ...
December 4, 2023 at 2:43 AM. The U.S. Supreme Court will hear oral arguments Monday in Harrington v. Purdue Pharma to determine whether a bankruptcy court can discharge claims against a party that ...
Under the agreement, Purdue Pharma would cease to exist and a new company, Knoa Pharma, would be created in its place. Knoa would distribute opioid addiction treatments and overdose reversal ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.